Skip to main content
Top
Published in: Respiratory Research 1/2006

Open Access 01-12-2006 | Research

Tissue fibrocytes in patients with mild asthma: A possible link to thickness of reticular basement membrane?

Authors: Kristian Nihlberg, Kristoffer Larsen, Anna Hultgårdh-Nilsson, Anders Malmström, Leif Bjermer, Gunilla Westergren-Thorsson

Published in: Respiratory Research | Issue 1/2006

Login to get access

Abstract

Background

Myofibroblasts, proposed as being derived from circulating fibrocytes, are considered to be important cells in thickening of the basement membrane in patients with asthma. We have studied the correlation of tissue fibrocyte levels to basement membrane thickness and the presence of fibrocytes in bronchoalveolar lavage fluid (BALF) in steroid-naive patients with mild asthma and controls.

Methods

Patients with mild asthma (n = 9) were recruited and divided into two categories based on whether or not fibroblast-like cells could be established from BALF. Non-asthmatic healthy subjects (n = 5) were used as controls. Colocalization of the fibrocyte markers CD34, CD45RO, procollagen I, and α-smooth muscle actin (α-SMA) were identified in bronchial biopsies from patients and controls by confocal microscopy. Kruskall-Wallis method was used to calculate statistical significance and Spearman coefficient of rank correlation was used to assess the degree of association.

Results

In patients with BALF fibroblasts, a 14-fold increase of tissue cells expressing CD34/CD45RO/α-SMA and a 16-fold increase of tissue cells expressing CD34/procollagen I was observed when compared to controls (p < 0.05). In contrast, patients without BALF fibroblasts displayed a 2-fold increase when compared to controls (p < 0.05). Fibrocytes were localized close to the basement membrane which was significantly thicker in patients with BALF fibroblasts when compared to the other two groups of subjects. Furthermore, basement membrane thickness could be correlated to the number of fibrocytes in tissue (r = 0.711). Fibroblasts-like cells were cultured from BALF where 17.6% of these cells expressed CD34, CD45RO and α-SMA.

Conclusion

These findings indicate a correlation between recruited fibrocytes in tissue and thickness of basement membrane. Fibroblast progenitor cells may therefore be important in airway remodeling in steroid-naive patients with mild asthma.
Literature
1.
go back to reference Cohn L, Elias JA, Chupp GL: Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004, 22:789–815.CrossRefPubMed Cohn L, Elias JA, Chupp GL: Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004, 22:789–815.CrossRefPubMed
2.
go back to reference Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST: Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003, 111:215–225.CrossRefPubMed Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST: Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003, 111:215–225.CrossRefPubMed
3.
go back to reference Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M: Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999, 160:725–729.CrossRefPubMed Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M: Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999, 160:725–729.CrossRefPubMed
4.
go back to reference Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, et al.: Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003, 167:78–82.CrossRefPubMed Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, et al.: Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003, 167:78–82.CrossRefPubMed
5.
go back to reference Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, et al.: Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004, 169:214–219.CrossRefPubMed Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, et al.: Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004, 169:214–219.CrossRefPubMed
6.
go back to reference Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349–363.CrossRefPubMed Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349–363.CrossRefPubMed
7.
go back to reference Abe S, Boyer C, Liu X, Wen FQ, Kobayashi T, Fang Q, et al.: Cells derived from the circulation contribute to the repair of lung injury. Am J Respir Crit Care Med 2004, 170:1158–1163.CrossRefPubMed Abe S, Boyer C, Liu X, Wen FQ, Kobayashi T, Fang Q, et al.: Cells derived from the circulation contribute to the repair of lung injury. Am J Respir Crit Care Med 2004, 170:1158–1163.CrossRefPubMed
8.
go back to reference Chesney J, Bacher M, Bender A, Bucala R: The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997, 94:6307–6312.CrossRefPubMedPubMedCentral Chesney J, Bacher M, Bender A, Bucala R: The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997, 94:6307–6312.CrossRefPubMedPubMedCentral
9.
go back to reference Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S: Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003, 171:380–389.CrossRefPubMed Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S: Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003, 171:380–389.CrossRefPubMed
10.
go back to reference Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71–81.PubMedPubMedCentral Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71–81.PubMedPubMedCentral
11.
go back to reference Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, et al.: CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005, 166:675–684.CrossRefPubMedPubMedCentral Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, et al.: CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005, 166:675–684.CrossRefPubMedPubMedCentral
12.
go back to reference Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S: Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005, 304:81–90.CrossRefPubMed Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S: Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005, 304:81–90.CrossRefPubMed
13.
go back to reference Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al.: Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004, 114:438–446.CrossRefPubMedPubMedCentral Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al.: Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004, 114:438–446.CrossRefPubMedPubMedCentral
14.
go back to reference Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556–7562.CrossRefPubMed Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556–7562.CrossRefPubMed
15.
go back to reference Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A: Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993, 92:632–637.CrossRefPubMedPubMedCentral Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A: Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993, 92:632–637.CrossRefPubMedPubMedCentral
16.
go back to reference Larsen K, Tufvesson E, Malmstrom J, Morgelin M, Wildt M, Andersson A, et al.: Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med 2004, 170:1049–1056.CrossRefPubMed Larsen K, Tufvesson E, Malmstrom J, Morgelin M, Wildt M, Andersson A, et al.: Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med 2004, 170:1049–1056.CrossRefPubMed
17.
go back to reference Malmstrom J, Larsen K, Hansson L, Lofdahl CG, Norregard-Jensen O, Marko-Varga G, et al.: Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2002, 2:394–404.CrossRefPubMed Malmstrom J, Larsen K, Hansson L, Lofdahl CG, Norregard-Jensen O, Marko-Varga G, et al.: Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2002, 2:394–404.CrossRefPubMed
18.
go back to reference Kasahara K, Shiba K, Ozawa T, Okuda K, Adachi M: Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002, 57:242–246.CrossRefPubMedPubMedCentral Kasahara K, Shiba K, Ozawa T, Okuda K, Adachi M: Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002, 57:242–246.CrossRefPubMedPubMedCentral
19.
go back to reference Erjefalt JS, Persson CG: New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med 2000, 161:2074–2085.CrossRefPubMed Erjefalt JS, Persson CG: New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med 2000, 161:2074–2085.CrossRefPubMed
20.
go back to reference Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:S28-S38.CrossRefPubMed Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:S28-S38.CrossRefPubMed
21.
go back to reference Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, et al.: Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002, 57:309–316.CrossRefPubMedPubMedCentral Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, et al.: Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002, 57:309–316.CrossRefPubMedPubMedCentral
22.
go back to reference Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK: Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997, 16:664–673.CrossRefPubMed Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK: Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997, 16:664–673.CrossRefPubMed
23.
go back to reference Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, et al.: Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005, 166:1321–1332.CrossRefPubMedPubMedCentral Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, et al.: Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005, 166:1321–1332.CrossRefPubMedPubMedCentral
24.
go back to reference Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al.: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858–864.CrossRefPubMed Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al.: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858–864.CrossRefPubMed
25.
26.
go back to reference Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, et al.: G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687–694.CrossRefPubMed Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, et al.: G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687–694.CrossRefPubMed
27.
go back to reference Hocking DC: Fibronectin matrix deposition and cell contractility: implications for airway remodeling in asthma. Chest 2002, 122:275S-278S.CrossRefPubMed Hocking DC: Fibronectin matrix deposition and cell contractility: implications for airway remodeling in asthma. Chest 2002, 122:275S-278S.CrossRefPubMed
Metadata
Title
Tissue fibrocytes in patients with mild asthma: A possible link to thickness of reticular basement membrane?
Authors
Kristian Nihlberg
Kristoffer Larsen
Anna Hultgårdh-Nilsson
Anders Malmström
Leif Bjermer
Gunilla Westergren-Thorsson
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2006
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-7-50

Other articles of this Issue 1/2006

Respiratory Research 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.